Isavuconazole shortens the QTc interval
Sign Up to like & getrecommendations! Published in 2018 at "Mycoses"
DOI: 10.1111/myc.12731
Abstract: Isavuconazole is a novel antifungal drug approved for the treatment of adults with invasive aspergillosis and mucormycosis. While azoles as a class effect are known to prolong QTc interval, clinical trials have shown that isavuconazole… read more here.
Keywords: isavuconazole shortens; qtc interval; shortens qtc; treatment ... See more keywords
Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15030375
Abstract: This work’s objective was to evaluate the safety of isavuconazole (ISA) as a treatment or prophylaxis for invasive fungal infections (IFIs) in immunocompromised children. IFI was reported as proven or probable according to international definitions.… read more here.
Keywords: fungal infections; infections pediatric; isavuconazole treatment; treatment invasive ... See more keywords